Navigation Links
ACRES Announces Strategic Alliance with Atlantis Global Research Institute

Cambridge, Massachusetts (PRWEB) September 26, 2013

The Atlantis Global Research Institute (AGRI) today announced that it will work with the Alliance for Clinical Research Excellence and Safety (ACRES) to accelerate development of the ACRES Global Network, a group of high performing sites connected through a shared technology platform as part of an open and global system for clinical research. To that end, AGRI has joined ACRES as a Strategic Alliance partner and will immediately begin registering all of its global research sites in the ACRES network.    

AGRI Managing Director, Robert Wallace, noted, “We are elated to become an ACRES Alliance member and to have our national and international research sites join the ACRES global network. We believe that medical innovation and progress come from the formation of synergistic partnerships that enable conduct of clinical trials globally through a centralized process and, most importantly, provide access to novel treatment options to patients across the globe. Our alliance with ACRES allows this vision to become a reality.”

AGRI has developed a proprietary structure that allows the bio-pharmaceutical, pharmaceutical, device and diagnostic industry to conduct their clinical trials in a more time and cost-efficient manner. AGRI’s methodology is propelling the clinical trial industry forward by reducing the overall time and costs involved with conducting clinical trials.

Founded in 2012 AGRI has already established itself as one of the fastest growing and most innovative global research institutes worldwide, with over 100 research sites across the globe.

“Like ACRES, AGRI is a young and rapidly growing organization, and we share a new vision for the future of clinical research,” said ACRES President and CEO, Dr. Greg Koski. “We are delighted that AGRI is among the first global clinical research organizations to partner with ACRES to begin building a truly global system of research sites dedicated to enhancing excellence and safety in clinical trials world-wide for the benefit of all.”


ACRES, a global non-profit organization based in Cambridge, Massachusetts, is working in the public interest to build a comprehensive, sustainable and shareable global system for clinical research. By bringing together experts, stakeholders and like-minded organizations, ACRES is creating and implementing systems solutions that will enhance safety, data quality and integrity in an efficient, collaborative and cost effective manner to improve the health and lives of people everywhere.

About AGRI

Atlantis Global Research Institute (AGRI) is pioneering changes in how global clinical research is conducted by developing synergistic partnerships, collaborations, and alliances to produce quality results in a more timely and cost-efficient manner.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. ACRES Launches Global Clinical Research Network Technology Platform
2. Announces Promotional T-Shirt and Other Specials for Neuroscience 2013
3. Cato Research Announces New Hires of Strategic Business Development Personnel
4. Gentris Corporation Partners with BioFortis, Announces New Vice President of Information Technology
5. Pets Best Insurance Announces Stem Cell Therapy and Regenerative Veterinary Medicine by Vet-Stem, Inc. Covered by Their Pet Health Insurance
6. Senomyx Announces Management Update
7. DTRA/SCC-WMD Announces $1 Million Algorithm Challenge Winner
8. Thermax Inc. Announces Price Increase on Ion Exchange Resins
9. Sangamo BioSciences Announces Closing Of $74.2 Million Public Offering Of Common Stock And Exercise Of Over-Allotment Option
10. Harwood Feffer LLP Announces Investigation of Verenium Corporation
11. Applied Integrin Sciences, Inc. Announces Exceptional Results In Ovarian Cancer Study
Post Your Comments:
(Date:6/27/2016)... ... 2016 , ... Newly created 4Sight Medical Solutions ... healthcare market. The company's primary focus is on new product introductions, to include ... are necessary to help companies efficiently bring their products to market. , The ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
Breaking Biology News(10 mins):